CAD 0.01
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2022 | -0.01 USD | 38.82% |
2021 | -0.02 USD | -16.44% |
2020 | -0.01 USD | 17.05% |
2019 | -0.02 USD | -36.43% |
2018 | -0.01 USD | 80.28% |
2017 | -0.07 USD | -28.49% |
2016 | -0.05 USD | 53.73% |
2015 | -0.11 USD | -95.04% |
2014 | -0.06 USD | 23.37% |
2013 | -0.07 USD | 79.56% |
2012 | -0.36 USD | -633.2% |
2011 | -0.05 USD | 55.36% |
2010 | -0.11 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q2 | -0.00 USD | -19.23% |
2023 Q1 | -0.00 USD | -225.0% |
2023 Q3 | -0.00 USD | 16.13% |
2022 Q4 | -0.00 USD | 75.0% |
2022 Q2 | -0.00 USD | 19.44% |
2022 Q3 | -0.00 USD | -10.34% |
2022 FY | - USD | 38.82% |
2022 Q1 | -0.00 USD | 50.68% |
2021 Q4 | -0.01 USD | -135.48% |
2021 Q1 | -0.00 USD | 29.41% |
2021 FY | - USD | -16.44% |
2021 Q2 | -0.00 USD | 22.22% |
2021 Q3 | -0.00 USD | -10.71% |
2020 Q4 | -0.01 USD | -30.77% |
2020 Q3 | -0.00 USD | -129.41% |
2020 Q2 | -0.00 USD | 55.26% |
2020 Q1 | -0.00 USD | -3700.0% |
2020 FY | - USD | 17.05% |
2019 Q3 | -0.00 USD | 36.76% |
2019 Q2 | -0.01 USD | 12.82% |
2019 FY | - USD | -36.43% |
2019 Q1 | -0.01 USD | -214.71% |
2019 Q4 | -0.00 USD | 97.67% |
2018 Q3 | -0.01 USD | -55.56% |
2018 Q2 | -0.01 USD | 30.77% |
2018 Q4 | 0.01 USD | 180.95% |
2018 Q1 | -0.01 USD | 78.09% |
2018 FY | - USD | 80.28% |
2017 Q3 | -0.01 USD | 25.0% |
2017 FY | - USD | -28.49% |
2017 Q4 | -0.04 USD | -415.94% |
2017 Q2 | -0.01 USD | 31.85% |
2017 Q1 | -0.01 USD | 23.3% |
2016 FY | - USD | 53.73% |
2016 Q4 | -0.02 USD | -58.56% |
2016 Q2 | -0.02 USD | -170.31% |
2016 Q1 | -0.01 USD | 86.24% |
2016 Q3 | -0.01 USD | 35.84% |
2015 FY | - USD | -95.04% |
2015 Q2 | -0.04 USD | -213.91% |
2015 Q3 | -0.02 USD | 37.95% |
2015 Q4 | -0.05 USD | -107.59% |
2015 Q1 | -0.01 USD | 49.56% |
2014 Q2 | -0.01 USD | -296.77% |
2014 FY | - USD | 23.37% |
2014 Q4 | -0.02 USD | -24.59% |
2014 Q3 | -0.02 USD | -48.78% |
2014 Q1 | -0.00 USD | 90.19% |
2013 Q4 | -0.03 USD | -20.61% |
2013 FY | - USD | 79.56% |
2013 Q1 | -0.02 USD | 97.2% |
2013 Q2 | -0.01 USD | 47.88% |
2013 Q3 | -0.03 USD | -204.65% |
2012 Q2 | -0.02 USD | 38.75% |
2012 Q1 | -0.03 USD | 31.62% |
2012 FY | - USD | -633.2% |
2012 Q3 | -0.01 USD | 63.27% |
2012 Q4 | -0.59 USD | -8094.44% |
2011 Q2 | -0.01 USD | -51.11% |
2011 Q3 | -0.00 USD | 82.35% |
2011 Q4 | -0.05 USD | -3800.0% |
2011 FY | - USD | 55.36% |
2011 Q1 | -0.00 USD | 95.09% |
2010 FY | - USD | 0.0% |
2010 Q3 | -0.01 USD | 98.97% |
2010 Q2 | -0.64 USD | 0.0% |
2010 Q4 | -0.09 USD | -1287.88% |
Name | Eps | Eps Difference |
---|---|---|
AI/ML Innovations Inc. | -0.06 CAD | 81.625% |
Diagnamed Holdings Corp. | -0.02 CAD | 36.196% |
Pangenomic Health Inc. | -0.30 CAD | 96.533% |
nDatalyze Corp. | -0.00 CAD | -160.0% |
Treatment.Com International Inc. | -0.26 CAD | 96.0% |
Unidoc Health Corp. | -0.04 CAD | 76.837% |